Where Will Viking Therapeutics Be in 5 Years?

We could be witnessing the birth of a major player in the biotech industry. Five years ago, Viking Therapeutics (VKTX 5.43%) was an unknown, clinical-stage biotech. It hardly stood out in a sea of small drugmakers, and most of those never end up producing the kinds of results or performances investors want to see. However, a lot has changed since: Viking still has no products on the market, but its leading candidates have made exciting clinical progress. That's why its shares soared this year. There is stil ...